Search

everythinglearnresearchcommunity

for

Search:↓

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.